Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Biotechnology
  • Calibr-Skaggs Administers First Patient with Switchable CAR-T Cell Therapy in Phase 1 Trial Targeting Metastatic Breast Cancer
calibr-skaggs-administers-first-patient-with-switchable-car-t-cell-therapy-in-phase-1-trial-targeting-metastatic-breast-cancer
Calibr-Skaggs Administers First Patient with Switchable CAR-T Cell Therapy in Phase 1 Trial Targeting Metastatic Breast Cancer

Calibr-Skaggs Administers First Patient with Switchable CAR-T Cell Therapy in Phase 1 Trial Targeting Metastatic Breast Cancer

June 17, 2025Posted inBiotechnology

nginx

Post navigation

Previous Post
mabion-launches-e500,000-services-contest-to-support-next-gen-oncology-advances Mabion Launches €500,000 Services Contest to Support Next-Gen Oncology Advances
Next Post
Thriving Habitats: The Flourishing World of Wild Bees thriving-habitats:-the-flourishing-world-of-wild-bees

Recent Posts

  • Scientists Discover New Connection to Triple-Negative Breast Cancer
  • NIH-Funded Neonatologist Physician-Scientists: Equity and Success
  • Novel Immunotherapy Combos Transform Advanced Liver Cancer Care
  • Preview of the AI for Good Global Summit 2025: An Exclusive Behind-the-Scenes Tour with ITU and United Nations
  • Breakthrough in Glioblastoma Research: FAU Secures Grants to Advance Brain Cancer Treatment

Archives

  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • March 2024
  • January 2024
  • September 2023

Privacy Policy    Terms

Scroll to Top